Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase NA 2

Status

Unknown 3

Sponsor Class

OTHER 71NIH 25INDUSTRY 17NETWORK 12UNKNOWN 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Triple Negative Breast Neoplasms 2Breast Neoplasms 2

Interventions

Paclitaxel 6Radiotherapy 3Epirubicin 3Radiotherapy, Intensity-Modulated 2Radiation Dose Hypofractionation 2Radiation 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Capecitabine 2pegylated granulocyte colony-stimulating factor 1nabiximols 1aumolertinib 1Zoledronic Acid 1Vinorelbine 1Temozolomide 1TP protocol 1Standard of Care 1S 1 (combination) 1Platinum 1Pemetrexed 1Neoadjuvant Therapy 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Drug Therapy 1Decitabine 1Chemotherapy, Adjuvant 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Epirubicin × Clear all
NCT03876886 2019-03-21

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

ChineseAMS

Phase 3 Unknown
200 enrolled
Breast

Triple Negative Breast Neoplasms

NCT01134523 2013-03-15

Regimens Comparison for Breast Cancers of Positive Lymph Nodes

ChineseAMS

Phase 3 Unknown
1,000 enrolled
Breast

Breast Neoplasms

NCT01378533 2011-12-28

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

ChineseAMS

Phase 3 Unknown
100 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡